SANGAMO THERAPEUTICS INC (SGMO) Institutional Ownership and Insiders Activity

SANGAMO THERAPEUTICS INC (SGMO) is widely held by institutional investors, with 6 firms reporting positions valued at approximately $35,036 based on SEC Form 13F filings for the quarter ended June 30, 2026.

Nomura Asset Management International Inc. is the largest disclosed holder, reporting approximately $22,000 in SGMO holdings in its latest filing.

Institutional ownership remains highly concentrated, with Nomura Asset Management International Inc. representing the majority of disclosed value.